Press release
What's Happening With Cardiovascular genomic diagnostics market? Color Genomics, Inc., Creative Diagnostics Thermo Fisher Scientific, Illumi-na, Inc., Admera Health, Blueprint Genetics Oy., Merck KGaA, MP Biomedicals, LLC., Helix OpCo LLC, CENTOGENE AG, a
Some of the Key manufacturers operating in the global cardiovascular genomic diagnostics market in-clude Gnome Diagnostics, Color Genomics, Inc., Creative Diagnostics Thermo Fisher Scientific, Illumi-na, Inc., Admera Health, Blueprint Genetics Oy., Merck KGaA, MP Biomedicals, LLC., Helix OpCo LLC, CENTOGENE AG, and Oasis Diagnostics Corporation. These players are adopting sophisticated tech-niques in the development of cardiovascular genomic diagnostics which will help them for expansion of their product offerings, strengthen geographical presence, and gain strong market share.
Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/28258
The global cardiovascular genomic diagnostics Market is segmented on the basis of product type and end user
On the basis of test type, the cardiovascular genomic diagnostics market is segmented into:
• Predictive Testing
o Genetic Susceptibility Test
o Predictive Diagnostics
o Population Screening
• Carrier Screening
• Prenatal Testing
• Genotyping
On the basis of disease indication, the cardiovascular genomic diagnostics market is segmented into:
• Congenital Heart Disease
• Cardiac Channelopathies
• Familial Hyper-Cholestrolaemia
• Cardiomyopathies
• Others
On the basis of technological platform, the cardiovascular genomic diagnostics market is segmented into:
• Generation Sequencing (NGS)
• Multiplex Ligation-Dependent Probe Amplification (MLPA)
On the basis of end users, the cardiovascular genomic diagnostics market is segmented into:
• Hospital Laboratories’
• Diagnostic Centers
• Contract Research Organizations (CROs)
• Others
The growing prevalence of heart diseases such as congenital heart disease, is expected to be the ma-jor factors that will drive the growth of the cardiovascular genomic diagnostics market over the forecast period. According to CDC, in 2013, heart disease was the leading cause of death in the US for amongst all the races. It is estimated that 1 in every 200 people inherit some form of heart disease and undergo cardiovascular genomic diagnostics. Besides, unhealthy eating and lifestyle practice increases the chances of cardiovascular disease and this drives the cardiovascular genomic diagnostics market. The market of cardiovascular genomic diagnostics help in diagnosis, prognosis, and management of heart related diseases. Also, the cardiovascular genomic diagnostics test is able to differentiate and confirm the diseased state from other sources. The cardiovascular genomic diagnostics testing also helps in the management of treatment options, which suppress the cardiac events. Cardiovascular genomic diagnostics testing kits provide rapid results with great efficiency.
Cardiovascular genomic diagnostics testing are used to prevent lives of patients. According to CDC, approximately 86 million people around the world suffer from at least one type of cardiovascular dis-ease. The procedure of cardiovascular genomic diagnostics are easy to perform and the results are obtained within 4-8 weeks. The global market for cardiovascular genomic diagnostics is expected to witness high growth over the forecast period. The cardiovascular genomic diagnostics market is ex-pected to increase due to rise in cardiac disorders amongst all age group population. Carrier screening undertaken by the government and implementation of mass screening programs is also expected to increase the demand for cardiovascular genomic diagnostics market. Both East and South Asia are an-ticipated to witness robust growth in cardiovascular genomic diagnostics over the forecast period owing to increase demand of these predictive tests in the developing economies of this region.
Get Full TOC @ https://www.persistencemarketresearch.com/toc/28258
Geographically, North America is anticipated to be the leading market in the global cardiovascular ge-nomic diagnostics market owing to the increasing number of cardiac diseases. Moreover, the regional market will also rise due to the technological advancement as well as stringent patient care and safety in the region. The cardiovascular genomic diagnostics markets in the South and East Asia are also an-ticipated to grow at a significant CAGR due to product expansion offerings by the major global players. In addition, cardiovascular genomic diagnostics is poised to improve the health of population globally by decreasing rate of heart attack and congenital heart diseases. Europe is expected to have the second largest share in the global cardiovascular genomic diagnostics market throughout the forecast period
The report covers exhaustive analysis on:
• Global Cardiovascular Genomic Diagnostics segments
• Global Cardiovascular Genomic Diagnostics dynamics
• Historical actual market size, 2013 - 2017
• Global Cardiovascular Genomic Diagnostics size & forecast 2018 to 2026
• Global Cardiovascular Genomic Diagnostics current trends/issues/challenges
• Competition & companies involved
• Global Cardiovascular Genomic Diagnostics drivers and restraints
Regional analysis includes:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Report Highlights:
• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance
Get Full Report @ https://www.persistencemarketresearch.com/market-research/cardiovascular-genomic-diagnostics-market.asp
ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's Happening With Cardiovascular genomic diagnostics market? Color Genomics, Inc., Creative Diagnostics Thermo Fisher Scientific, Illumi-na, Inc., Admera Health, Blueprint Genetics Oy., Merck KGaA, MP Biomedicals, LLC., Helix OpCo LLC, CENTOGENE AG, a here
News-ID: 1770885 • Views: …
More Releases from persistencemarketresearch.com
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers…
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers.
Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is…
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or…
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia…
More Releases for Cardiovascular
Increasing Prevalence of Cardiovascular Diseases to Augment the Cardiovascular I …
Cardiovascular information system offers on-time access to cardiovascular electronic medical records in reports, images, and waveforms, and allows easy report generation and distribution. Cardiovascular information system is extensively used in electrocardiography (ECG) data management, echocardiography, catheterization, and vascular solutions.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/20
Cardiovascular information system is used to store, archive, and share healthcare information. It is a unique software solution that helps improve the clinical and financial…
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region.
Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,…
Mexico Cardiovascular Devices Market Outlook to 2025 Cardiac Assist Devices, Car …
Orbisresearch.com has announced the addition of Mexico Cardiovascular Devices Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Mexico Cardiovascular Devices Market Outlook to 2025, provides key market data on the Mexico Cardiovascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Cardiac Assist Devices, Cardiac Rhythm…
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven…
Increasing Cardiovascular Surgeries Leads To Higher Market Value For Cardiovascu …
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,…
Cardiovascular Monitoring and Diagnostic Devices Market to be Driven with the Ri …
The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder…
